Colitis, Ulcerative
23 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| AC-101 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Atorvastatin calcium trihydrate for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bezlotoxumab for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Duvakitug for colitis, ulcerative | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Emvistegrast for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Fecal Microbial Transplantation for colitis, ulcerative | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Golimumab for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Guselkumab for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| INT-210 Capsule for colitis, ulcerative | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| JNJ-78934804 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mirikizumab for colitis, ulcerative | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Obefazimod for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| PALI-2108 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Phentermine-Topiramate for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo-to-match emvistegrast + Emvistegrast for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| single FMT for colitis, ulcerative | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| SPY001 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY001 + SPY002 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY001 + SPY003 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY002 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY002 + SPY003 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| SPY003 for colitis, ulcerative | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Vedolizumab for colitis, ulcerative | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |